A Study of the Effectiveness and Safety of Nivolumab Compared to Bevacizumab and of Nivolumab With or Without Ipilimumab in Glioblastoma Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

529

Participants

Timeline

Start Date

February 7, 2014

Primary Completion Date

June 17, 2019

Study Completion Date

June 21, 2024

Conditions
Recurrent Glioblastoma
Interventions
BIOLOGICAL

Nivolumab

specified dose on specified days

BIOLOGICAL

Bevacizumab

specified dose on specified days

BIOLOGICAL

Ipilimumab

specified dose on specified days

Trial Locations (112)

1090

Local Institution - 0050, Brussels

Local Institution, Brussels

1200

Local Institution - 0051, Brussels

Local Institution, Brussels

2170

Local Institution - 0035, Liverpool

Local Institution, Liverpool

3084

Local Institution - 0033, Heidelberg

Local Institution, Heidelberg

3165

Local Institution - 0034, East Bentleigh

Local Institution, East Bentleigh

5000

Local Institution - 0057, Odense C

Odense University Hospital, Odense C

6009

Local Institution - 0032, Nedlands

Local Institution, Nedlands

8000

Aarhus University Hospital, Aarhus C

Local Institution - 0058, Aarhus C

8091

Local Institution - 0040, Zurich

UniversitaetsSpital Zurich, Zurich

10065

Local Institution - 0003, New York

Memorial Sloan Kettering Cancer Center, New York

10126

Azienda Ospedaliera Citta della Salute e della Scienza, Torino

Local Institution - 0013, Torino

13385

Local Institution - 0063, Marseille

Local Institution, Marseille

19107

Thomas Jefferson University - Clinical Research Institute, Philadelphia

Thomas Jefferson University, Philadelphia

20007

Georgetown University, Washington D.C.

20133

Local Institution - 0011, Milan

Local Institution, Milan

21287

Johns Hopkins University School Of Medicine, Baltimore

Local Institution - 0008, Baltimore

22908

University Of Virginia Health System, Charlottesville

27710

Local Institution - 0007, Durham

Preston Robert Tisch Brain Tumor Center at Duke University, Durham

28009

Local Institution - 0045, Madrid

Local Institution, Madrid

28041

Local Institution - 0046, Madrid

Local Institution, Madrid

28204

Levine Cancer Institute, Charlotte

29425

Local Institution - 0023, Charleston

Medical University Of South Carolina, Charleston

30322

Local Institution - 0002, Atlanta

Winship Cancer Institute, Atlanta

31008

Local Institution - 0070, Pamplona

Local Institution, Pamplona

33612

Moffitt Cancer Center, Tampa

37232

Local Institution - 0005, Nashville

Vanderbilt University Medical Center, Nashville

40139

Local Institution - 0010, Bologna

Local Institution, Bologna

44106

Local Institution - 0049, Cleveland

University Hospitals Cleveland Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

48149

Local Institution - 0041, Münster

Universitaetsklinikum Muenster, Münster

48202

Henry Ford Health System, Detroit

53100

Local Institution - 0012, Siena

Local Institution, Siena

53127

Local Institution - 0037, Bonn

Universitaetsklinikum Bonn, Bonn

55905

Mayo Clinic, Rochester

60528

Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main, Frankfurt am Main

Local Institution - 0036, Frankfurt am Main

69120

Local Institution - 0038, Heidelberg

Local Institution, Heidelberg

69677

Local Institution - 0062, Bron

Local Institution, Bron

75010

Local Institution - 0068, Paris

Local Institution, Paris

75651

Local Institution - 0064, Paris

Local Institution, Paris

80045

Anschutz Cancer Pavilion, Aurora

Local Institution - 0021, Aurora

90048

Cedars Sinai Medical Center, Los Angeles

Local Institution - 0055, Los Angeles

98109

University of Washington - Seattle Cancer Care Alliance, Seattle

98122

Local Institution - 0020, Seattle

Swedish Neuroscience Institute, Seattle

35294-3410

University of Alabama at Birmingham, Birmingham

90095-1769

Local Institution - 0009, Los Angeles

UCLA Neuro-Oncology Program, Los Angeles

94143-0372

Local Institution - 0014, San Francisco

The Regents of the University of California, San Francisco, San Francisco

06520

Local Institution - 0001, New Haven

Yale University School Of Medicine, New Haven

02215

Beth Israel Deaconess Med Ctr, Boston

Dana-Farber Cancer Institute, Boston

Local Institution - 0006, Boston

Local Institution - 0043, Boston

Local Institution - 0056, Boston

Massachusetts General Hospital, Boston

48202-2608

Henry Ford Health System, Detroit

77030-4009

Local Institution - 0024, Houston

University Of Texas Md Anderson Cancer Ctr, Houston

1066CX

Local Institution - 0067, Amsterdam

Local Institution, Amsterdam

9713 AP

Local Institution - 0066, Groningen

Local Institution, Groningen

80-952

Local Institution - 0060, Gdansk

Local Institution, Gdansk

02-781

Local Institution - 0059, Warsaw

Local Institution, Warsaw

08035

Local Institution - 0047, Barcelona

Local Institution, Barcelona

BT 02252

Centre hospitalier universitaire Vaudois (CHUV), Lausanne

Local Institution - 0039, Lausanne

NW1 2PG

Local Institution - 0018, London

Local Institution, London

M20 4BX

Local Institution - 0015, Manchester

Local Institution, Manchester

L7 8YA

Local Institution - 0017, Liverpool

Local Institution, Liverpool

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY